Pediatrics, RheumatologyAbout Dr. Taber
Dr. Sarah Taber specializes in the diagnosis and treatment of children with rheumatic diseases, including juvenile idiopathic arthritis, childhood systemic lupus, dermatomyositis, vasculitis, and systemic and localized scleroderma. She graduated Phi Beta Kappa and Magna Cum Laude from Yale University, and from the Icahn School of Medicine at Mount Sinai, which she attended through the prestigious Humanities and Medicine program.
Dr. Taber completed her residency in pediatrics at NYU Medical Center, where she was selected Outstanding Floor Senior Resident upon graduation. She then completed her fellowship in pediatric rheumatology at Hospital for Special Surgery and Weill Cornell Medical Center. Dr. Taber has been a featured speaker for the Scleroderma Foundation, Charla de Lupus, Arthritis Foundation, and A Lasting Mark Foundation, and is a Consult Editor of Rheumatology for Medscape. She is a member of the Scleroderma, Vasculitis and Rare Diseases group of the Childhood Arthritis and Rheumatology Research Alliance. She is board certified in both pediatrics and pediatric rheumatology.
Profile Video
Departments
Special Expertise
Childhood arthritis, childhood systemic lupus erythematosus, vasculitis, localized scleroderma, systemic sclerosis, juvenile dermatomyositis, fever of unknown origin, autoinflammatory disease
Patient Stories
Videos
Insurance
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor of Pediatrics, Weill Cornell Medical College
Affiliations
American College of Rheumatology
American Academy of Pediatrics
Childhood Arthritis and Rheumatology Research Alliance (CARRA)
Certification
American Board of Pediatrics
Awards
Phi Beta Kappa, 2005
Magna Cum Laude, 2005
Education
Medical School: Icahn School of Medicine at Mount Sinai
Internship: New York University School of Medicine
Residency: New York University School of Medicine
Fellowship: Hospital for Special Surgery, New York
State Licensure
Languages
English
Publications by Dr. Taber
For all publications, please see the PubMed listing.
Patient Education
- Juvenile Idiopathic Arthritis
- Systemic Juvenile Idiopathic Arthritis
- Reactive Arthritis in Children and Adolescents
- Inflammatory Arthritis in Children: More than Growing Pains
Professional Education
- Hereditary Fibrosing Poikiloderma with Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) in a 4-Year-Old with a History of Anti-Synthetase Syndrome
- Kikuchi–Fujimoto Disease in a 6-Year-Old Boy with a History of Macrophage Activation Syndrome
- Pachydermodactyly, a Rare and Benign Digital Fibromatosis, Diagnosed in a 15-Year-Old Boy
Selected Presentations
Trachtman R, Murray E, Szymonifka J, Adams A, Pan N, Taber S, Lehman T, Onel K, Mandl L. Do Patient Reported Outcome Measurement Information System (PROMIS) Computer Adaptive Tests Correlate with Disease Activity in Juvenile Idiopathic Arthritis? PHO Conference: PROMIS in Action, Poster Presentation
Trachtman R, Murray E, Szymonifka J, Toussi S, Nellis M, Adams A, Pan N, Taber S, Lehman T, Onel K, Mandl L. Procalcitonin Differentiates Infection from Active Disease in Patients with Juvenile Idiopathic Arthritis. ACR/ARHP Annual Meeting 2017, Poster Presentation
Treemarcki E, Syzmonifka J, Adams A, Pan N, Taber S, Onel K. “A Weighty Diagnosis: Weight Change and Risk Factors in Early Juvenile Systemic Lupus Erythematosus.” ACR/ARHP Annual Meeting 2018, Poster Presentation
Research
Research Interests
Localized scleroderma, systemic sclerosis, whole genome sequencing, gene expression studies
Industry Relationships
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of March 27, 2023, Dr. Taber reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.